180 related articles for article (PubMed ID: 31915881)
1. [Comparison of T cell response in the tumor milieu of patients with HPV
Bastian T; Lang S; Kansy BA
HNO; 2020 Feb; 68(2):80-86. PubMed ID: 31915881
[TBL] [Abstract][Full Text] [Related]
2. The interplay between HPV and host immunity in head and neck squamous cell carcinoma.
Andersen AS; Koldjaer Sølling AS; Ovesen T; Rusan M
Int J Cancer; 2014 Jun; 134(12):2755-63. PubMed ID: 23913554
[TBL] [Abstract][Full Text] [Related]
3. Peritumoral cuffing by T-cell tumor-infiltrating lymphocytes distinguishes HPV-related oropharyngeal squamous cell carcinoma from oral cavity squamous cell carcinoma.
Poropatich K; Hernandez D; Fontanarosa J; Brown K; Woloschak G; Paintal A; Raparia K; Samant S
J Oral Pathol Med; 2017 Nov; 46(10):972-978. PubMed ID: 28632936
[TBL] [Abstract][Full Text] [Related]
4. Impact of HPV Infection on the Immune System in Oropharyngeal and Non-Oropharyngeal Squamous Cell Carcinoma: A Systematic Review.
Lechien JR; Seminerio I; Descamps G; Mat Q; Mouawad F; Hans S; Julieron M; Dequanter D; Vanderhaegen T; Journe F; Saussez S
Cells; 2019 Sep; 8(9):. PubMed ID: 31510065
[TBL] [Abstract][Full Text] [Related]
5. Systemic and local human papillomavirus 16-specific T-cell immunity in patients with head and neck cancer.
Heusinkveld M; Goedemans R; Briet RJ; Gelderblom H; Nortier JW; Gorter A; Smit VT; Langeveld AP; Jansen JC; van der Burg SH
Int J Cancer; 2012 Jul; 131(2):E74-85. PubMed ID: 22020783
[TBL] [Abstract][Full Text] [Related]
6. Gene expression analysis of TIL rich HPV-driven head and neck tumors reveals a distinct B-cell signature when compared to HPV independent tumors.
Wood O; Woo J; Seumois G; Savelyeva N; McCann KJ; Singh D; Jones T; Peel L; Breen MS; Ward M; Garrido Martin E; Sanchez-Elsner T; Thomas G; Vijayanand P; Woelk CH; King E; Ottensmeier C;
Oncotarget; 2016 Aug; 7(35):56781-56797. PubMed ID: 27462861
[TBL] [Abstract][Full Text] [Related]
7. Type I conventional dendritic cells and CD8
Kirchner J; Plesca I; Rothe R; Resag A; Löck S; Benešová I; Rupp L; Linge A; Wehner R; Krause M; Schmitz M
Front Immunol; 2024; 15():1414298. PubMed ID: 38938577
[TBL] [Abstract][Full Text] [Related]
8. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
[TBL] [Abstract][Full Text] [Related]
9. The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas.
Kong CS; Narasimhan B; Cao H; Kwok S; Erickson JP; Koong A; Pourmand N; Le QT
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):553-61. PubMed ID: 19427557
[TBL] [Abstract][Full Text] [Related]
10. DETECTION OF HUMAN PAPILLOMA VIRUS IN HEAD AND NECK SQUAMOUS CELL CARCINOMAS: A LITERATURE REVIEW.
Jelihovschi I; Bidescu AC; Tucaliuc SE; Iancu LS
Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):502-9. PubMed ID: 26204659
[TBL] [Abstract][Full Text] [Related]
11. [Immune System in Patients with Head and Neck Carcinoma].
Partlová S; Bouček J; Kloudová K; Zábrodský M; Špíšek R; Fialová A
Klin Onkol; 2015; 28 Suppl 4():4S86-94. PubMed ID: 26647896
[TBL] [Abstract][Full Text] [Related]
12. Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients.
Aarstad HJ; Vintermyr OK; Ulvestad E; Aarstad HH; Kross KW; Heimdal JH
APMIS; 2015 Apr; 123(4):305-14. PubMed ID: 25801083
[TBL] [Abstract][Full Text] [Related]
13. PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer.
Badoual C; Hans S; Merillon N; Van Ryswick C; Ravel P; Benhamouda N; Levionnois E; Nizard M; Si-Mohamed A; Besnier N; Gey A; Rotem-Yehudar R; Pere H; Tran T; Guerin CL; Chauvat A; Dransart E; Alanio C; Albert S; Barry B; Sandoval F; Quintin-Colonna F; Bruneval P; Fridman WH; Lemoine FM; Oudard S; Johannes L; Olive D; Brasnu D; Tartour E
Cancer Res; 2013 Jan; 73(1):128-38. PubMed ID: 23135914
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of B lymphocyte infiltration in HPV
Zhang S; Wang B; Ma F; Tong F; Yan B; Liu T; Xie H; Song L; Yu S; Wei L
Cancer Sci; 2021 Apr; 112(4):1402-1416. PubMed ID: 33529452
[TBL] [Abstract][Full Text] [Related]
15. CD8
Masterson L; Lechner M; Loewenbein S; Mohammed H; Davies-Husband C; Fenton T; Sudhoff H; Jani P; Goon P; Sterling J
Eur J Cancer; 2016 Nov; 67():141-151. PubMed ID: 27669501
[TBL] [Abstract][Full Text] [Related]
16. [The tumor microenvironment-relay station for prognosis and therapy response].
Krupar R
Pathologie (Heidelb); 2022 Aug; 43(Suppl 1):141-147. PubMed ID: 36414699
[TBL] [Abstract][Full Text] [Related]
17. Immunologic and metabolic characteristics of HPV-negative and HPV-positive head and neck squamous cell carcinomas are strikingly different.
Krupar R; Robold K; Gaag D; Spanier G; Kreutz M; Renner K; Hellerbrand C; Hofstaedter F; Bosserhoff AK
Virchows Arch; 2014 Sep; 465(3):299-312. PubMed ID: 25027580
[TBL] [Abstract][Full Text] [Related]
18. CD8+ and CD4+ tumour infiltrating lymphocytes in relation to human papillomavirus status and clinical outcome in tonsillar and base of tongue squamous cell carcinoma.
Nordfors C; Grün N; Tertipis N; Ährlund-Richter A; Haeggblom L; Sivars L; Du J; Nyberg T; Marklund L; Munck-Wikland E; Näsman A; Ramqvist T; Dalianis T
Eur J Cancer; 2013 Jul; 49(11):2522-30. PubMed ID: 23571147
[TBL] [Abstract][Full Text] [Related]
19. Increased radiosensitivity of HPV-positive head and neck cancers: Molecular basis and therapeutic perspectives.
Mirghani H; Amen F; Tao Y; Deutsch E; Levy A
Cancer Treat Rev; 2015 Dec; 41(10):844-52. PubMed ID: 26476574
[TBL] [Abstract][Full Text] [Related]
20. Clinico-pathological peculiarities of human papilloma virus driven head and neck squamous cell carcinoma: A comprehensive update.
Devaraja K; Aggarwal S; Verma SS; Gupta SC
Life Sci; 2020 Mar; 245():117383. PubMed ID: 32007572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]